Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Clinical trial NCT01922089 · COMPLETED

Trial details

NCT number: NCT01922089
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction

Start date: 2013-11-01
Primary completion: 2014-08-01
Enrollment: 498

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.